Clearing House Whup Whup Hut

[PoemStone]

MICRO Insider. COCO. SQNM.
http://investorshub.advfn.com/boards/board.aspx?board_id=17034

COCO--Insider purchased 100k shares at $2.54. Stock closed at $2.66. Everybody knows I was a big COCO homer over the past year or so, so I am not purchasing stock on this play because I have a lot of options on it, but I believe it will be an easy 8%'er. Do your own research.

insider data provided by www.scumfish.com

Corinthian Colleges, Inc. (Corinthian) is a post-secondary education company in the United States and Canada, serving the segment of the population seeking to acquire career-oriented education. As of June 30, 2010, the Company had a student enrollment of 110,580 and operated 101 schools in 25 states, and 17 schools in the province of Ontario, Canada. As of August 13, 2010 all of its schools operated under one of three national brands, Everest, WyoTech, or Heald. As of June 30, 2010, 101 out of 118 schools were operating under the Everest brand, six schools were operating under the WyoTech brand, and 11 schools were operating under the Heald brand. The Company offers a variety of diploma programs and associate's, bachelors and master's degrees through a single operating segment. Its training program areas include healthcare, criminal justice, mechanical, trades, business and information technology. On January 4, 2010, the Company completed its acquisition of Heald Capital, LLC.

.................................................................

SQNM--VP purchased 20k shares at $4.24. Stock closed at $4.24. Do your own research, but nice volume / share structure.

insider data provided by www.scumfish.com

Sequenom, Inc. (Sequenom) is a diagnostic testing and genetics analysis company. The Company is focused on providing products, services, diagnostic testing, applications and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock and other areas of research. Its development and commercialization efforts in various diagnostic areas include non-invasive women's health-related and prenatal diagnostics, ophthalmology, oncology, infectious diseases, and other medical conditions, disorders and diseases. The Company has two segments: Molecular Diagnostics and Genetic Analysis.